LAIYANG, China, June 03, 2008 /Xinhua-PRNewswire-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (''Genesis'' or the ''Company''), a leading pharmaceutical company in the People's Republic of ...
OKOTOKS, Alberta, May 22, 2025 (GLOBE NEWSWIRE) -- (TSX: MTL) Mullen Group Ltd. (MTL:CA) ("Mullen Group", "We", "Our" and/or the "Corporation") today announced that it has priced an approximately ...
The Private Placement includes (i) $650 million aggregate principal amount of 3.709% Series 1 senior unsecured notes due September 12, 2030 (the "2030 Notes") and (ii) $350 million aggregate principal ...
The Notes Offering is expected to close on July 10, 2025, subject to the satisfaction of customary closing conditions. Mullen Group intends to use the net proceeds from the Notes Offering to prepay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback